Fig. 1 · Structure
Documents & Downloads
Linogliride fumarate
Antidiabetic Agent
Linogliride fumarate is an antidiabetic agent that primarily targets pancreatic beta cells. It exhibits a significant insulinotropic effect when glucose is present, specifically at a concentration of 5.5 mM, while having no effect on insulin secretion in the absence of glucose. This compound is valuable for research into diabetes management and the mechanisms of insulin secretion regulation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 78782-47-5 |
| Applications | Antidiabetic Agent |
| Formula | C20H26N4O5 |
| Molecular Weight | 402.44 |
| Synonyms | McN-3935 fumarate |
| SMILES | CN1/C(CCC1)=N/C(N2CCOCC2)=N/C3=CC=CC=C3.O=C(O)/C=C/C(O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.